Valéria Petri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Valéria Petri has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bodo Wanke
Laboratory Medical Mycology National Institute of Infectious Diseases Evandro Chagas Oswaldo Cruz Foundation (INI‐FIOCRUZ) Rio de Janeiro Brazil
1 shared publication - Delson da Silva
Fundação Oswaldo Cruz Escola Nacional de Saúde Pública Departamento de Endemias Samuel Pessoa
1 shared publication M. M. A. Alchorne
Department of Dermatology, Universidade Federal de São Paulo – Escola Paulista de Medicina, São Paulo, Brazil
1 shared publication- Márcia Lazéra
Fundação Oswaldo Cruz Centro de Pesquisa Hospital Evandro Chagas Serviço de Micologia
1 shared publication O. Rotta
Department of Dermatology, Universidade Federal de São Paulo – Escola Paulista de Medicina, São Paulo, Brazil
1 shared publication- Paulo Chagastelles Sabroza
Laboratório de Monitoramento Epidemiológico de Grandes Empreendimentos, Fiocruz, Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 October 2002
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 18 (5) , 1441-1454
Paracoccidioidomycosis mortality in Brazil (1980-1995)
This study analyzes 3,181 deaths from paracoccidioidomycosis in Brazil, based on 16 years of sequential data (from 1980 to 1995). During this period paracoccidioidomycosis showed considerable magnitude and low visibility, representing the eighth most common cause of death from predominantly chronic or recurrent types of infectious and parasitic diseases. It also had the highest mortality rate among the systemic mycoses. The mean annual mortality rate was 1.45 per million inhabitants, indicating a downward long-term trend (reduction of 31.28%), while spatial distribution among the different regions and States of Brazil was non-homogenous. The South (with the highest regional rate) and the Southeast showed a downward trend, while the Central West had the second highest rate in the country. At least one-fifth of Brazilian municipalities (or 22.71% of the country's total area) reported deaths from paracoccidioidomycosis. Overall nationwide mortality per area was 3.73/10,000km². The disease was endemic in non-metropolitan areas. The majority of deaths occurred in males (84.75%), and there was a sex ratio of 562 men/100 women. The 30-59-year and over-60-year age groups were the most affected. The study showed that the mortality rate justifies classifying this disease as a major health problem in Brazil.
- 1 October 2002
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 18 (5) , 1441-1454
Open AccessParacoccidioidomycosis mortality in Brazil (1980-1995)
This study analyzes 3,181 deaths from paracoccidioidomycosis in Brazil, based on 16 years of sequential data (from 1980 to 1995). During this period paracoccidioidomycosis showed considerable magnitude and low visibility, representing the eighth most common cause of death from predominantly chronic or recurrent types of infectious and parasitic diseases. It also had the highest mortality rate among the systemic mycoses. The mean annual mortality rate was 1.45 per million inhabitants, indicating a downward long-term trend (reduction of 31.28%), while spatial distribution among the different regions and States of Brazil was non-homogenous. The South (with the highest regional rate) and the Southeast showed a downward trend, while the Central West had the second highest rate in the country. At least one-fifth of Brazilian municipalities (or 22.71% of the country's total area) reported deaths from paracoccidioidomycosis. Overall nationwide mortality per area was 3.73/10,000km². The disease was endemic in non-metropolitan areas. The majority of deaths occurred in males (84.75%), and there was a sex ratio of 562 men/100 women. The 30-59-year and over-60-year age groups were the most affected. The study showed that the mortality rate justifies classifying this disease as a major health problem in Brazil.
- 1 September 2000
- Published by Wiley in Pediatric Dermatology
- Vol. 17 (5) , 410-414
Oral Treatment of Crusted Scabies with Ivermectin: Report of Two Cases
Oral treatment with ivermectin of crusted (Norwegian) scabies in two immunosuppressed patients is reported. There was resolution of symptoms and signs of the cutaneous parasitosis on administration of 18–36 mg ivermectin (total doses) in 2- and 3-week periods of treatment, with remission periods of 3 and 4 months, respectively.
- 1 September 2000
- Published by Wiley in Pediatric Dermatology
- Vol. 17 (5) , 410-414
Oral Treatment of Crusted Scabies with Ivermectin: Report of Two Cases
Oral treatment with ivermectin of crusted (Norwegian) scabies in two immunosuppressed patients is reported. There was resolution of symptoms and signs of the cutaneous parasitosis on administration of 18–36 mg ivermectin (total doses) in 2- and 3-week periods of treatment, with remission periods of 3 and 4 months, respectively.